<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref36">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Deng</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>A. P.</given-names>
   </name>
   <name>
    <surname>Maia</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Lim</surname>
    <given-names>J. J.</given-names>
   </name>
   <name>
    <surname>Burgess</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Horn</surname>
    <given-names>P.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2018</year>). 
  <article-title>Pharmacokinetics of MHAA4549A, an anti-influenza A monoclonal antibody, in healthy subjects challenged with influenza A virus in a phase IIa randomized trial</article-title>. 
  <source>Clin. Pharmacokinet.</source>
  <volume>57</volume>, 
  <fpage>367</fpage>â€“
  <lpage>377</lpage>. 
  <pub-id pub-id-type="doi">10.1007/s40262-017-0564-y</pub-id>, PMID: 
  <?supplied-pmid 28639229?>
  <pub-id pub-id-type="pmid">28639229</pub-id>
 </mixed-citation>
</ref>
